Commissioning for rare diseases: view from the frontline

被引：28

作者：

Burls, A ^{[1
]}

Austin, D

Moore, D

机构：

[1] Univ Birmingham, Dept Epidemiol & Publ Hlth, W Midlands Hlth Technol Assessment Collaborat, Birmingham B15 2TT, W Midlands, England

[2] W Midlands Specialised Serv Agcy, Birmingham B16 9RG, W Midlands, England

来源：

BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7523期

关键词：

D O I：

10.1136/bmj.331.7523.1019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1019 / 1021

页数：3

共 12 条

[1]

*AGGR RES INT FAC, 2004, REC HUM ALPH L ID TR

[2]

*AGGR RES INT FAC, 2004, REC HUM ALPH GAL TRE

[3]

[Anonymous], VIEWS PUBLIC FUNDING

[4]

*CAN COORD OFF HLT, 2005, LAR CEDAC FIN REC RE

[5]

CONNOCK MJ, IN PRESS HLTH TECHNO

[6]

*DEP HLTH, MECH FUND NSCAG

[7]

*DEP HLTH, 2003, GUID COMM RANG SPEC

[8]

*DEP HLTH, 2005, NATL SPEC COMM ADV G

[9] Orphan drugs and the NHS: should we value rarity? [J].

McCabe, C ;

Claxton, K ;

Tsuchiya, A .

BRITISH MEDICAL JOURNAL, 2005, 331 (7523) :1016-1019

[10]

*NAT SPEC COMM ADV, 2005, LYS STOR DIS NSCAGS